These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3895923)

  • 1. Single-agent therapy for infections in neutropenic cancer patients.
    Fainstein V; Bodey GP
    Am J Med; 1985 Aug; 79(2A):83-8. PubMed ID: 3895923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
    Zinner SH; Dudley M; Blaser J
    Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L; Wells H; Lange BJ
    Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of empiric antibiotic therapy for the febrile neutropenic patient.
    Schimpff SC
    Rev Infect Dis; 1985; 7 Suppl 4():S734-40. PubMed ID: 3878564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer.
    Wade JC; Standiford HC; Drusano GL; Johnson DE; Moody MR; Bustamante CI; Joshi JH; deJongh C; Schimpff SC
    Am J Med; 1985 Jun; 78(6A):62-72. PubMed ID: 3859217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of choice for the empiric treatment of the febrile neutropenic patient.
    Barriere SL
    Drug Intell Clin Pharm; 1986 Oct; 20(10):767-9. PubMed ID: 3769764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime as a single agent in the management of children with fever and neutropenia.
    Morgan G; Duerden BI; Lilleyman JS
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():347-51. PubMed ID: 6352641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
    Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients?
    Hathorn JW; Pizzo PA
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():41-54. PubMed ID: 3519563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
    Klastersky J
    Rev Med Brux; 1997 Oct; 18(5):323-7. PubMed ID: 9441328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combating infections in neutropenic patients.
    Pizzo PA
    Hosp Pract (Off Ed); 1989 Jul; 24(7):93-100, 103-4, 107-10. PubMed ID: 2501330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy.
    Johnson MP; Ramphal R
    J Infect Dis; 1990 Oct; 162(4):981-3. PubMed ID: 2205658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical antibiotics for febrile neutropenic cancer patients.
    Hathorn JW
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
    Rolston KV; Bodey GP; Elting L
    Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antibacterial agents: the role of new penicillins and cephalosporins in the management of infection in granulocytopenic patients.
    Klastersky J
    Clin Haematol; 1984 Oct; 13(3):587-98. PubMed ID: 6388934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients.
    Klastersky J
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):201S-207S. PubMed ID: 2686921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monotherapy for empirical management of febrile neutropenic patients.
    Rubin M; Pizzo PA
    NCI Monogr; 1990; (9):111-6. PubMed ID: 2160613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy.
    Wade JC
    Rev Infect Dis; 1989; 11 Suppl 7():S1572-81. PubMed ID: 2690295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.